Effect of Bioptron Light on Carpal Tunnel Syndrome(BLCTS)

Last updated: January 17, 2024
Sponsor: Cairo University
Overall Status: Active - Recruiting

Phase

N/A

Condition

Carpal Tunnel Syndrome

Treatment

bioptron light therapy

wrist brace

Clinical Study ID

NCT06209918
P.T.REC/012/003875
  • Ages 25-35
  • Female

Study Summary

The purpose of this study is to investigate the effect of bioptron light therapy on pregnancy related carpal tunnel syndrome

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Pregnant females clinically daignosed with carpal tunnel syndrome at least 1 month
  • age will range from (25-35) years.
  • body mass index (BMI) will be (BMI ≤ 35 kg/m2)

Exclusion

Exclusion Criteria:

  • history of neurologic disease
  • hand surgery
  • hand trauma,
  • diabetes mellitus
  • cervical spondylosis
  • osteoarthritis of cervical spine and wrist joint
  • chronic renal failure
  • heart failure
  • connective tissue disorders

Study Design

Total Participants: 62
Treatment Group(s): 2
Primary Treatment: bioptron light therapy
Phase:
Study Start date:
July 01, 2023
Estimated Completion Date:
December 31, 2024

Study Description

Carpal tunnel syndrome (CTS) is a symptomatic compression neuropathy of the median nerve at the level of the wrist, characterized by hand pain, numbness, and tingling in the distribution of the median nerve (thumb, index, middle finger, and the radial side of the ring finger) and a reduction in grip strength and hand function. The severity of symptoms can be clinically categorized into mild, moderate, and severe Bioptron phototherapy acts as a "sterile" trigger on human in vitro isolated peripheral blood mononuclear cells (PBMCs), affecting their cytokine production and driving the immune response towards an anti-inflammatory/reparative profile and representing a non-pharmaceutical and non-invasive option for several clinical conditionsA randomized control study, the women will be randomly assigned into two groups, (31 women for each group) equal in number. Group (A) will include 31 women will receive Bioptron light combined with advice and patient education (10 minutes per session, 3 sessions per week, for 4 weeks). Group (B) will be receiving advice only for same duration as group (A)

Connect with a study center

  • Sara Magdy Ahmed

    Giza,
    Egypt

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.